Le Lézard
Classified in: Health
Subjects: PDT, FDA

BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System



FRANKLIN LAKES, N.J., July 19, 2017 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the BD FACSLyrictm flow cytometer system, an easy-to-use in vitro diagnostic (IVD) system, for use with BD Multitesttm assays for immunological assessment of individuals and patients having or suspected of having immune deficiency.

BD FACSLyricTM Flow Cytometer System

The BD FACSLyric system strengthens BD's portfolio of clinical flow cytometry solutions available in the U.S. The system was CE marked to the EU IVD Directive last year.

The new flow cytometer system combines a benchtop-sized instrument with software, reagents and services to provide clinicians and scientists with accurate, reliable and repeatable results.

"The FDA clearance of the BD FACSLyric system continues BD's drive to increase access to new innovations in clinical flow cytometry technology to more labs around the world," said John Ledek, president of Biosciences for BD. "BD recognizes that products for the clinical market require ease of use and standardization from instrument to instrument to ensure consistent results that ultimately inform patient care."

BD FACSLyric supports the BD Multitesttm 4-Color assays and the BD Multitesttm 6-Color TBNK assay, which are some of the most used flow-based IVD assays. These tests determine the percentages and absolute counts of T, B and natural killer (NK) cells, as well as the CD4 and CD8 subsets of T cells. Together, these metrics can be used in the immunological assessment of individuals and patients having, or suspected of having, immune deficiency. The BD FACSLyric cell analyzer is available in four configurations to provide laboratories with the flexibility to adapt to changing clinical needs. More IVD assays will be added to the BD FACSLyric solution as they become available.

The BD FACSLyric system is available as an IVD instrument in the U.S., Europe and other geographies. For more information, visit bdbiosciences.com.

About BD
BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease and cancer, improve medication management, promote infection prevention, equip surgical and interventional procedures, and support the management of diabetes. The company partners with organizations around the world to address some of the most challenging global health issues. BD has nearly 50,000 associates across 50 countries who work in close collaboration with customers and partners to help enhance outcomes, lower health care delivery costs, increase efficiencies, improve health care safety and expand access to health. For more information on BD, please visit bd.com.

Contacts:




Gwen Gordon   

Monique N. Dolecki

BD Public Relations

BD Investor Relations

858.812.3724  

201.847.5378

gwen.gordon@bd.com  

monique_dolecki@bd.com

 

SOURCE BD (Becton, Dickinson and Company)


These press releases may also interest you

at 00:32
SIMI VALLEY, Calif., Oct. 24, 2017 /PRNewswire/ -- EazyHold has received its patent for the first silicone grip aids. Designed for use at home, hospitals and schools, it's one of the simplest ways to solve the universal problem of poor hand function...

23 oct 2017
DALLAS, Oct. 23, 2017 /PRNewswire/ -- HealthMine survey data underscores that the way members connect to health plans directly relates to how members prefer to receive help about their health.  Eighty-nine percent (89%) of those 64-years old and...

23 oct 2017
LAS VEGAS, Oct. 23, 2017 /PRNewswire-USNewswire/ -- The Economic Club of Las Vegas, a nationally renowned platform for economic discussion and debate, has announced it will host a panel of healthcare experts in Las Vegas on Thursday, October 26th,...

23 oct 2017
CARROLLTON, Texas, Oct. 23, 2017 /PRNewswire/ -- Hospice Source, LLC announced today that it has purchased certain assets of Specialized Medical Services and Premier Medical Corporation in the markets of East Tennessee, New Mexico, and Houston,...

23 oct 2017
GRAPEVINE, Texas, Oct. 23, 2017 /PRNewswire/ -- Support raised through Get in the Game, a luncheon aimed at increasing awareness of domestic violence resources available in North Texas, will assist The Gatehouse, a community supporting domestic...

23 oct 2017
NASHVILLE, Tenn., Oct. 23, 2017 /PRNewswire/ -- HealthCombix, a global decentralized healthcare development company, announced today Mr. Matthew Conboy has joined the company Advisory Board.   Mr. Conboy is a health care professional with a...




News published on 19 july 2017 at 06:59 and distributed by: